SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001487118-23-000003
Filing Date
2023-03-02
Accepted
2023-03-02 16:26:20
Documents
1
Group Members
ICS OPPORTUNITIES, LTD.ISRAEL A. ENGLANDERMILLENNIUM GROUP MANAGEMENT LLCMILLENNIUM MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 ALBO_SC13G.htm SC 13G 94067
  Complete submission text file 0001487118-23-000003.txt   95893
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Subject) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-83386 | Film No.: 23699375
SIC: 2834 Pharmaceutical Preparations

Mailing Address MILLENNIUM INTERNATIONAL MANAGEMENT LP 399 PARK AVENUE NEW YORK NY 10022
Business Address MILLENNIUM INTERNATIONAL MANAGEMENT LP 399 PARK AVENUE NEW YORK NY 10022 (212) 841-4100
ICS OPPORTUNITIES, LTD. (Filed by) CIK: 0001487118 (see all company filings)

IRS No.: 980537566 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G